College of Chemistry, Chemical Engineering and Materials Science, Soochow University, 199 Ren'ai Road, Suzhou 215123, Jiangsu, P. R. China.
Center for Soft Condensed Matter Physics and Interdisciplinary Research, Soochow University, Suzhou 215006, P. R. China.
ACS Appl Mater Interfaces. 2021 Aug 11;13(31):36859-36867. doi: 10.1021/acsami.1c08785. Epub 2021 Aug 2.
Glycopolymer-based drugs for immunotherapy have attracted increasing attention because the affinity between glycans and proteins plays an important role in immune responses. Previous studies indicate that the polymer chain length influences the affinity. In the studies on enhancing the immune response by glycans, it is found that both oligosaccharides and long-chain glycopolymers work well. However, there is a lack of systematic studies on the immune enhancement effect and the binding ability of oligomers and polymers to immune-related proteins. In this paper, to study the influence of the chain length, glycopolymers based on -acetylglucosamine with different chain lengths were synthesized, and their interaction with immune-related proteins and their effect on dendritic cell maturation were evaluated. It was proved that compared with l-glycopolymers (degree of polymerization (DP) > 20), s-glycopolymers (DP < 20) showed better binding ability to the dendritic cell-specific ICAM-3-grabbing nonintegrin protein and the toll-like receptor 4 and myeloid differentiation factor 2 complex protein by quartz crystal microbalance and molecular docking simulation. When the total sugar unit amounts are equal, s-glycopolymers are proved to be superior in promoting dendritic cell maturation by detecting the expression level of CD80 and CD86 on the surface of dendritic cells. Through the combination of experimental characterization and theoretical simulation, a deep look into the interaction between immune-related proteins and glycopolymers with different chain lengths is helpful to improve the understanding of the immune-related interactions and provides a good theoretical basis for the design of new glycopolymer-based immune drugs.
基于糖聚合物的免疫疗法药物引起了越来越多的关注,因为糖链与蛋白质之间的亲和力在免疫反应中起着重要作用。先前的研究表明,聚合物链长会影响亲和力。在通过糖增强免疫反应的研究中,发现低聚糖和长链糖聚合物都能很好地发挥作用。然而,对于低聚物和聚合物与免疫相关蛋白的结合能力和免疫增强效果,缺乏系统的研究。在本文中,为了研究链长的影响,合成了不同链长的基于 N-乙酰葡萄糖胺的糖聚合物,并评估了它们与免疫相关蛋白的相互作用及其对树突状细胞成熟的影响。结果证明,与 l-糖聚合物(聚合度(DP)>20)相比,s-糖聚合物(DP<20)通过石英晶体微天平(QCM)和分子对接模拟显示出更好的与树突状细胞特异性 ICAM-3 抓取非整联蛋白和 Toll 样受体 4 与髓样分化因子 2 复合物蛋白的结合能力。当总糖单元数量相同时,通过检测树突状细胞表面 CD80 和 CD86 的表达水平,证明 s-糖聚合物在促进树突状细胞成熟方面具有优越性。通过实验表征和理论模拟的结合,深入了解具有不同链长的免疫相关蛋白与糖聚合物之间的相互作用,有助于提高对免疫相关相互作用的理解,并为设计基于新糖聚合物的免疫药物提供良好的理论依据。